| H2A. Z facilitates licensing and activation of early replication origins H Long, L Zhang, M Lv, Z Wen, W Zhang, X Chen, P Zhang, T Li, L Chang, ... Nature 577 (7791), 576-581, 2020 | 120 | 2020 |
| Discovery of novel chemoeffectors and rational design of Escherichia coli chemoreceptor specificity S Bi, D Yu, G Si, C Luo, T Li, Q Ouyang, V Jakovljevic, V Sourjik, Y Tu, ... Proceedings of the National Academy of Sciences 110 (42), 16814-16819, 2013 | 54 | 2013 |
| Massively parallel base editing to map variant effects in human hematopoiesis JD Martin-Rufino, N Castano, M Pang, EI Grody, S Joubran, A Caulier, ... Cell 186 (11), 2456-2474. e24, 2023 | 36 | 2023 |
| Novel inhibitors of toxin HipA reduce multidrug tolerant persisters T Li, N Yin, H Liu, J Pei, L Lai ACS medicinal chemistry letters 7 (5), 449-453, 2016 | 29 | 2016 |
| Structural basis for ligand reception by anaplastic lymphoma kinase T Li, SE Stayrook, Y Tsutsui, J Zhang, Y Wang, H Li, A Proffitt, SG Krimmer, ... Nature 600 (7887), 148-152, 2021 | 26 | 2021 |
| Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617 L Peng, Y Hu, MC Mankowski, P Ren, RE Chen, J Wei, M Zhao, T Li, ... Nature communications 13 (1), 1638, 2022 | 13 | 2022 |
| ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK. CAR-T cells E Bergaggio, WT Tai, A Aroldi, C Mecca, E Landoni, M Nüesch, I Mota, ... Cancer cell 41 (12), 2100-2116. e10, 2023 | 7 | 2023 |
| RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq P Ren, L Peng, L Yang, K Suzuki, Z Fang, PA Renauer, Q Lin, M Bai, T Li, ... Cell Chemical Biology 30 (1), 85-96. e6, 2023 | 1* | 2023 |
| ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK. CAR-T cells E Bergaggio, WT Tai, A Aroldi, C Mecca, E Landoni, M Nüesch, I Mota, ... Cancer Research 84 (6_Supplement), 50-50, 2024 | | 2024 |
| Physical basis for the interaction between Drosophila ROS1 and the GPCR BOSS J Zhang, Y Tsutsui, H Li, T Li, Y Wang, DE Klein bioRxiv, 2024.03. 13.584817, 2024 | | 2024 |
| 317 ALK chimeric antigen receptor T cells cooperate with ALK inhibitors to target neuroblastoma cells with low target density E Bergaggio, WT Tai, A Aroldi, E Landoni, M Nuesch, I Mota, J Metovic, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
Daryl Ewald KleinYale UniversityVerified email at yale.edu
